← All stocks

MUSTANG BIO, INC.

MBIO Net buying
CIK 0001680048 #5478 in the set updated 21 Sep 2026
Bought (120 mo)
$2.85M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$122.29K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$122.29K
12 of 12 sales
Net
+$2.73M
+$2.73M against sales at will

By person

9 insiders · 35 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Litchman Manuel MD
President, CEO and Interim CFO
$2.35M (14)
$37.61K (2)
+$2.31M
1,615
$1.55K
ROSENWALD LINDSAY A MD
Director
$492.11K (4)
+$492.11K
60,525
$58.23K
Achenbach Brian
SVP, Fin. & Corp. Controller
$10.50K (3)
$84.43K (8)
−$73.94K
144,729
$139.23K
Herskowitz Neil
Director
$3.96K (1)
$237.61 (1)
+$3.72K
145
$139.49
Jin David
Director
$237.61 (1)
+$237.61
286
$275.13
+633.3%
Chill Adam J.
Director
$3.82 (1)
−$3.82
375
$360.75
Fortress Biotech, Inc. entity
10% owner
536,577
$516.19K
WEISS MICHAEL S
Director
164,257
$158.02K
+427.3%
ZELEFSKY MICHAEL J
Director
18,970
$18.25K

No percentages here. This company's share count has moved by a factor of 9.3 over the window, from 720,911 to 6,732,970 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 64
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 6,480,187
Sales filed before the plan box existed 10
History held since 7 Jun 2017